Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Spectrum Pharmaceuticals Inc

+ Add to Watchlist

SPPI:US

6.3050 USD 0.2450 4.04%

As of 20:10:00 ET on 03/04/2015.

Snapshot for Spectrum Pharmaceuticals Inc (SPPI)

Open: 6.1300 Day's Range: 6.0400 - 6.3300 Volume: 1,884,651
Previous Close: 6.0600 52wk Range: 5.6500 - 9.2700 1-Yr Rtn: -25.12%

Stock Chart for SPPI

No chart data available.
  • SPPI:US 6.3050
  • 1D
  • 1M
  • 1Y
6.0600
Interactive SPPI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SPPI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.2414
Est. EPS (USD) (12/2014) -0.6870
Est. PEG Ratio -
Market Cap (M USD) 414.62
Shares Outstanding (M) 65.76
30 Day Average Volume 1,421,668
Price/Book (mrq) 1.6170
Price/Sale (ttm) 2.2851
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.1500
Dividend Ex-Date 12/18/2012
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SPPI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SPPI

Spectrum Pharmaceuticals Inc. is a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology. The Company's strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products.

Rajesh C ShrotriyaChairman/CEOJoseph TurgeonPresident/COO
Kurt A GustafsonExec VP/CFOLee F AllenSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for SPPI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil